ProShares Ultra Nasdaq Biotechnology
Price through Oct 2 · Flows through Oct 2. Figures use the latest available records, not a live quote. Fund details retrieved Oct 2. Holdings snapshot retrieved Oct 2.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN · NET −$50M OVER THIS RANGE
Money is leaving — −$3M in net outflows over the past month, about 3.6% of the fund's asset base, while the price has returned +37.6% so far this year. At 0.95% a year it is not the cheapest way in — JDOC has a reported fee of 0.65%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
| 1 week | -4.0% |
| 1 month | -9.8% |
| 3 months | +2.8% |
| 6 months | +34.7% |
| YTD | +37.6% |
| 1 year | +73.2% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | −$3M |
| 3 months | +$2M |
| YTD | −$17M |
| 1 year | −$11M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Due diligence cuts both ways. These funds sit on the same shelf and beat BIB on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IVV iShares Core S&P 500 ETF | 0.03% | $882.6B | +$4.6B | -92bp on fee · 9518× the assets · +$4.6B in over the month | Head-to-head |
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -92bp on fee · 447× the assets · +$286M in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.4B | +$187M | -93bp on fee · 101× the assets · +$187M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -92bp on fee · 196× the assets · +$199M in over the month | Head-to-head |
| SPYG State Street SPDR Portfolio S&P 500 Growth ETF | 0.04% | $56.2B | +$717M | -91bp on fee · 606× the assets · +$717M in over the month | Head-to-head |